Dapagliflozin does not show improvement in glycemic control in moderate renal impairment: a question of analytical rigor?
- PMID: 25427091
- DOI: 10.1038/ki.2014.290
Dapagliflozin does not show improvement in glycemic control in moderate renal impairment: a question of analytical rigor?
Comment in
-
The authors reply.Kidney Int. 2014 Dec;86(6):1272. doi: 10.1038/ki.2014.291. Kidney Int. 2014. PMID: 25427094 No abstract available.
Comment on
-
Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control.Kidney Int. 2014 Apr;85(4):962-71. doi: 10.1038/ki.2013.356. Epub 2013 Sep 25. Kidney Int. 2014. PMID: 24067431 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical